샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777773

세계의 동물 모델 시장

Animal Model
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 383 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 동물 모델 시장은 2030년까지 37억 달러에 이를 전망

2024년에 24억 달러로 추정되는 동물 모델 세계 시장은 2024-2030년간 CAGR 7.4%로 성장하여 2030년에는 37억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 마우스는 CAGR 8.8%를 나타내고, 분석 기간 종료시에는 12억 달러에 이를 것으로 예측됩니다. 래트 부문의 성장률은 분석 기간에 CAGR 7.5%로 추정됩니다.

미국 시장은 6억 5,460만 달러로 추정, 중국은 CAGR11.8%로 성장 예측

미국의 동물 모델 시장은 2024년에 6억 5,460만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년간 CAGR 11.8%로 2030년까지 7억 8,830만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 3.7%와 7.2%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 4.9%를 나타낼 전망입니다.

세계의 동물 모델 시장 - 주요 동향과 촉진요인 정리

생물 의학 연구에서 동물 모델에 대한 수요가 증가하는 이유는 무엇인가?

생물 의학 및 제약 연구에서 동물 모델에 대한 의존도가 높아짐에 따라 시장 성장의 주요 촉진요인으로 작용하고 있습니다. 암, 당뇨병, 신경퇴행성 질환 등 만성질환의 유병률이 지속적으로 증가함에 따라 새로운 치료제의 안전성과 유효성을 평가하기 위한 전임상시험의 필요성이 높아지고 있습니다. 동물모델은 인간의 생리와 병리를 충실하게 모방한 생물학적 시스템을 제공함으로써 중개연구에서 중요한 역할을 하며, 연구자들은 질병 메커니즘에 대한 중요한 통찰력을 얻을 수 있습니다. 개인 맞춤형 의료와 유전자 치료에 대한 관심이 높아지면서 특정 인간의 유전적 상태를 시뮬레이션할 수 있는 유전자 변형 동물 모델에 대한 수요가 더욱 가속화되고 있습니다. 또한, FDA나 EMA와 같은 규제기관은 인간 대상 의약품을 승인하기 전에 동물모델을 이용한 전임상시험을 의무화하고 있어, 의약품 개발 파이프라인에서 동물모델의 중요성이 더욱 커지고 있습니다.

기술의 발전은 어떻게 동물 모델 시장을 형성하고 있는가?

유전공학 및 생명공학의 혁신은 연구용으로 보다 정밀하고 신뢰할 수 있는 동물 모델 개발에 혁명을 일으키고 있습니다. CRISPR-Cas9 유전자 편집 기술의 개발로 특이성이 높은 유전자 변형 동물 모델 제작이 가능해져 연구자들은 질병의 발생과 진행에 있어 특정 유전자의 역할을 연구할 수 있게 되었습니다. 동물 연구에 인공지능(AI)과 데이터 분석의 통합은 생리적, 행동학적 반응의 자동 추적을 가능하게 함으로써 조사의 정확성을 향상시키고 있습니다. 또한, 3D 바이오프린팅과 장기 온칩 기술의 발전은 기존의 동물 모델을 보완하여 보다 정확하고 윤리적으로 책임감 있는 연구를 수행할 수 있는 능력을 향상시키고 있습니다. 이러한 기술의 발전은 전임상 연구의 재현성과 신뢰성을 향상시킬 뿐만 아니라, 재생의료와 독성시험의 새로운 가능성을 열어주고 있습니다.

동물 모델 시장에 존재하는 과제와 기회는 무엇인가?

동물 모델 시장은 윤리적 문제, 규제 당국의 감시, 대체 시험 방법의 가용성 등 여러 가지 문제에 직면해 있습니다. 연구에서의 동물 사용을 둘러싼 윤리적 논쟁은 엄격한 가이드라인과 동물보호단체의 압력으로 이어졌고, 업계는 시험관 내 모델, 컴퓨터 시뮬레이션 등 동물 이외의 대안을 모색하게 되었습니다. 규제기관은 동물복지에 대한 컴플라이언스 요건을 강화하고 있으며, 이는 제약 및 연구기관 시장 상황을 더욱 복잡하게 만들고 있습니다. 그러나 이러한 도전은 시장 관계자들에게는 연구 성과를 극대화하고 고통을 최소화하면서 보다 정교하고 인도적인 동물 모델을 개발할 수 있는 기회이기도 합니다. 인간의 병리를 더 잘 재현하기 위해 인간의 세포와 유전자를 접목한 인간화 동물 모델의 채택이 증가하고 있는 것도 종양학, 면역학, 감염학 연구에 새로운 길을 열어주고 있습니다.

동물 모델 시장의 성장을 가속하는 주요 요인은?

동물 모델 시장의 성장은 새로운 치료제에 대한 수요 증가, 생물 의학 연구에 대한 정부 자금 지원 확대, 동물 모델 기반 연구가 필요한 인수공통전염병의 확산 증가 등 여러 요인에 의해 주도되고 있습니다. 제약사들은 혁신적인 의약품 및 생물학적 제제 개발을 위해 전임상 연구에 많은 투자를 하고 있으며, 이는 신뢰할 수 있는 유효성 및 안전성 데이터를 제공할 수 있는 고급 동물 모델에 대한 수요를 불러일으키고 있습니다. 특히 신종 감염병과 세계 건강 위협을 고려한 백신 개발에 대한 관심이 높아지면서 시장이 더욱 활성화되고 있습니다. 또한, 가축의 생산성과 반려동물의 건강을 개선하기 위한 수의학 연구에서 동물 모델의 사용이 증가하면서 시장 확대에 기여하고 있습니다. 유전공학과 분자생물학의 끊임없는 발전으로 동물모델 시장은 지속적인 성장을 이루며 전 세계 연구기관과 업계 이해관계자들에게 새로운 기회를 제공합니다.

부문

동물 유형(마우스, 래트, 몰모트, 햄스터, 기타 동물 유형);용도(암 용도, 감염증 용도, 면역질환 용도, 기타 용도);최종 용도(제약 기업 및 바이오테크놀러지 기업, 수탁 연구기관, 학술연구기관)

조사 대상 기업 예

  • Biocytogen Boston Corp.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience Inc.
  • Cyagen US Inc.
  • Genoway S.A.
  • Hera Biolabs
  • InnoSer Belgie NV
  • Inotiv, Inc.
  • Janvier Labs
  • Ozgene Pty Ltd.
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.04

Global Animal Model Market to Reach US$3.7 Billion by 2030

The global market for Animal Model estimated at US$2.4 Billion in the year 2024, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Mice, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Rat segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$654.6 Million While China is Forecast to Grow at 11.8% CAGR

The Animal Model market in the U.S. is estimated at US$654.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$788.3 Million by the year 2030 trailing a CAGR of 11.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Animal Model Market - Key Trends & Drivers Summarized

Why Is the Demand for Animal Models Rising in Biomedical Research?

The growing reliance on animal models in biomedical and pharmaceutical research is a key driver of market growth. As the prevalence of chronic diseases such as cancer, diabetes, and neurodegenerative disorders continues to rise, there is an increasing need for preclinical studies to evaluate the safety and efficacy of new therapeutics. Animal models play a crucial role in translational research by providing a biological system that closely mimics human physiology and pathology, allowing researchers to gain critical insights into disease mechanisms. The expanding focus on personalized medicine and gene therapy has further accelerated demand for genetically modified animal models that can simulate specific human genetic conditions. Additionally, regulatory bodies such as the FDA and EMA mandate preclinical testing using animal models before approving drugs for human trials, further cementing their importance in the drug development pipeline.

How Are Technological Advancements Shaping the Animal Model Market?

Innovations in genetic engineering and biotechnology are revolutionizing the development of more precise and reliable animal models for research applications. Advances in CRISPR-Cas9 gene-editing technology have enabled the creation of genetically modified animal models with high specificity, allowing researchers to study the role of specific genes in disease development and progression. The integration of artificial intelligence (AI) and data analytics in animal research is also improving study accuracy by enabling the automated tracking of physiological and behavioral responses. Furthermore, the increasing adoption of 3D bioprinting and organ-on-chip technologies is complementing traditional animal models, enhancing the ability to conduct more accurate and ethically responsible research. These technological advancements are not only improving the reproducibility and reliability of preclinical studies but are also opening up new opportunities in regenerative medicine and toxicology testing.

What Challenges and Opportunities Exist in the Animal Model Market?

The animal model market faces several challenges, including ethical concerns, regulatory scrutiny, and the availability of alternative testing methods. Ethical debates surrounding the use of animals in research have led to stringent guidelines and increased pressure from animal rights organizations, prompting the industry to explore non-animal alternatives such as in vitro models and computer simulations. Regulatory agencies are imposing stricter compliance requirements related to animal welfare, further complicating the market landscape for pharmaceutical and research institutions. However, these challenges present opportunities for market players to develop more refined and humane animal models that minimize suffering while maximizing research outcomes. The increasing adoption of humanized animal models, which incorporate human cells or genes to better replicate human conditions, is also opening new avenues for research in oncology, immunology, and infectious diseases.

What Are the Key Factors Driving Growth in the Animal Model Market?

The growth in the Animal Model market is driven by several factors, including the rising demand for novel therapeutics, expanding government funding for biomedical research, and the increasing prevalence of zoonotic diseases that require animal model-based studies. Pharmaceutical companies are investing heavily in preclinical research to develop innovative drugs and biologics, fueling demand for sophisticated animal models that can provide reliable efficacy and safety data. The growing focus on vaccine development, particularly in light of emerging infectious diseases and global health threats, is further boosting the market. Additionally, the rising use of animal models in veterinary research to improve livestock productivity and companion animal health is contributing to market expansion. With continuous advancements in genetic engineering and molecular biology, the animal model market is poised for sustained growth, offering new opportunities for research institutions and industry stakeholders worldwide.

SCOPE OF STUDY:

The report analyzes the Animal Model market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Animal Type (Mice, Rat, Guinea Pig, Hamster, Other Animal Types); Application (Cancer Application, Infectious Disease Application, Immunological disease Application, Other Applications); End-Use (Pharma and Biotech Companies End-Use, Contract Research Organizations End-Use, Academic Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Biocytogen Boston Corp.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience Inc.
  • Cyagen US Inc.
  • Genoway S.A.
  • Hera Biolabs
  • InnoSer Belgie NV
  • Inotiv, Inc.
  • Janvier Labs
  • Ozgene Pty Ltd.
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Animal Model - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Preclinical Research in Drug Development Drives the Growth of Animal Model Usage
    • Technological Advancements in Genetic Engineering Enhance the Precision and Reliability of Animal Models
    • Increasing Regulatory Requirements for Drug Safety and Efficacy Strengthen the Business Case for Animal Models
    • Expansion of Biopharmaceutical and Biotechnology Industries Spurs Demand for Advanced Animal Model Testing
    • Growing Emphasis on Personalized Medicine Fuels Demand for Genetically Modified and Humanized Animal Models
    • Rising Prevalence of Chronic Diseases Encourages the Use of Animal Models in Biomedical Research
    • Ethical Concerns and Alternative Testing Methods Present Challenges and Opportunities for Market Innovation
    • Collaborations Between Academic Institutions and Pharmaceutical Companies Drive New Developments in Animal Model Research
    • Increasing Government and Private Funding for Life Sciences Research Boosts Market Growth for Animal Models
    • Emergence of Alternative 3D Culture Systems and In-Vitro Models Pose Competitive Challenges for Animal Testing
    • Expansion of Cancer Research and Oncology Studies Strengthens Demand for Rodent-Based Animal Models
    • Rising Use of Large Animal Models in Regenerative Medicine Research Enhances Market Potential
    • Technological Innovations in Imaging and Monitoring Systems Improve the Efficiency of Animal Model Studies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Animal Model Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Animal Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Animal Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Mice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Mice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Mice by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Rat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Rat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Rat by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Guinea Pig by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Guinea Pig by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Guinea Pig by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hamster by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hamster by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hamster by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Animal Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Contract Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Academic Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Academic Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Academic Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Infectious Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Infectious Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Infectious Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Immunological disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Immunological disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Immunological disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Animal Model by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Animal Model by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Animal Model by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Animal Model by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Animal Model by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Animal Model by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Animal Model by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Animal Model by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Animal Model Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Animal Model by Animal Type - Mice, Rat, Guinea Pig, Hamster and Other Animal Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Animal Model by Animal Type - Percentage Breakdown of Value Sales for Mice, Rat, Guinea Pig, Hamster and Other Animal Types for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Animal Model by End-Use - Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Animal Model by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Contract Research Organizations End-Use and Academic Research Institutes End-Use for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Animal Model by Application - Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Animal Model by Application - Percentage Breakdown of Value Sales for Cancer Application, Infectious Disease Application, Immunological disease Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제